SEMAGLUTIDE WEIGHT-LOSS SHOTS
Scroll Down
WHAT TO KNOW
FDA Approved in 2021
Weekly Injections
Amazing Weight Loss Results!
Minimal Side Effects
Affordable
Marketed under the brand names OZEMPIC and WEGOVY.
94% similar to a naturally occurring hormone called glucagon-like peptide (GLP-1).
Stimulates the pancreas to produce additional insulin.
Decreases the stomach's emptying time and signaling to the brain a feeling of fullness and decrease in food craving.
People who take this weekly have altered food preferences and consume smaller portion sizes.
Lowers caloric consumption.
Targets increased abdominal fat in woman due to hormonal imbalances due to age, hysterectomies and PCOS.
Clinical trials have shown people lose an average of 15-20% of their starting weight.
Long-term success requires the combination of regular scheduled shots, exercise and behavioral habits.
SEMAGLUTIDE FACTS
RECCOMENDED FOR:
Anyone struggling to lose weight with a BMI over 30 or those with a BMI of 27 with at least one weight related comorbidity.
Such as Type 2 Diabetes,
High Cholesterol
or Hypertension
NOT RECCOMENDED FOR:
If you or anyone in your family has ever had a rare type of thyroid cancer know as Medullary Thyroid Carcinoma (MTC)
You are breastfeeding or pregnant
You have Multiple Endocrine Neoplasia Syndrome Type 2 (MEN 2)
COMMON SIDE EFFECTS
Abdominal Pain
Constipation
Nausea
Vomiting
Indigestion
